跳至主要内容
临床试验/NCT03602651
NCT03602651已完成不适用

MAGZEN® Effect on Recent Anxiety Reaction (STRESS2)

Laboratoire Dielen1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2019年11月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
110
试验地点
1
主要终点
number of "responders patients"

研究概览

简要总结

Multicentres, observational study, prospective, to evaluate the effect of MAGZEN® in the treatment of recent anxiety reaction.

详细描述

107 patients suffering from recent anxiety reaction will be included in the study. They will be treated by MAGZEN® during 4 weeks and we will study the effect of this treatment on the evolution of their anxiety after the cure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patient suffering from recent anxiety reaction
  • •Hamilton-anxiety score ≥ 20 at inclusion
  • •recent anxiety disorders (less than 3 months) not treated by pharmacological or psychological treatment

排除标准

  • •major depressive syndrome
  • •anxiety disorders more than 3 months
  • •anxiety due to death

结局指标

主要结局

number of "responders patients"

时间窗: 4 weeks

number (%) of "responders patients" with a diminution of the HAM-A score ≥ 50 %

次要结局

未报告次要终点

研究者

发起方
Laboratoire Dielen
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验